Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab
Titel:
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab
Auteur:
Pierga, J.-Y. Bidard, F.-C. Autret, A. Petit, T. Andre, F. Dalenc, F. Levy, C. Ferrero, J.-M. Romieu, G. Bonneterre, J. Lerebours, F. Bachelot, T. Kerbrat, P. Campone, M. Eymard, J.-C. Mouret-Reynier, M.-A. Gligorov, J. Hardy-Bessard, A.-C. Lortholary, A. Soulie, P. Boher, J.-M. Proudhon, C. Charafe-Jaufret, E. Lemonnier, J. Bertucci, F. Viens, P.